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Abstract Because inhibition of integrin signaling induces apo-
ptosis, we investigated whether keratinocytes expressing L1 and
K6L4 integrins (enriched for stem cells) are protected from cell
death. Keratinocytes rapidly adhering to type IV collagen ex-
pressed highest levels of L1 and K6L4 and of the anti-apoptotic
stem cell marker p63. Apoptotic cells were signi¢cantly higher
in slowly adhering than in rapidly adhering keratinocytes. Anti-
L1 integrin caused a signi¢cant increase in apoptotic cells, while
it decreased Bcl-2 levels in stem keratinocytes. Bax and Bad
proteins were higher in slowly adhering than in rapidly adhering
cells. By contrast, Bcl-2, Bcl-x and Mcl-1 proteins were highest
in rapidly adhering keratinocytes and nearly absent in slowly
adhering cells. After addition of anti-L1 integrin, the apoptotic
rate was signi¢cantly higher in HaCaT cells not expressing
Bcl-2 than in controls. These results indicate that keratinocytes
enriched for stem cells are protected from apoptosis via L1
integrin, in a Bcl-2 dependent manner. , 2002 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
The ability of human epidermis to maintain a constant
turnover of cells is based on the presence in the basal layer
of a population of keratinocyte stem cells that retains a high
capacity of self-renewal throughout life [1,2]. Stem cells gen-
erate transit amplifying (TA) cells that terminally di¡erentiate
after a discrete number of cell divisions [3,4]. A third popula-
tion (‘young’ TA) of basal keratinocytes behaves in an inter-
mediate way between stem and TA cells [5]. Epidermal kera-
tinocytes with the characteristics of stem and TA cells can be
identi¢ed and isolated on the basis of their adhesive capacity
[6]. Basal keratinocytes which rapidly adhere to type IV col-
lagen and express highest levels of L1 integrin, have the great-
est colony forming e⁄ciency (CFE), thus showing character-
istics of stem cells. On the other hand, basal cells expressing
lower amounts of L1 integrin, slowly adhering to the extracel-
lular matrix (ECM), tend to be committed to terminal di¡er-
entiation after few divisions [7,8]. Recently, a stem cell pop-
ulation has been isolated based on the expression of high
levels of K6L4 integrin and low levels of a proliferation-related
marker [9]. Finally, the transcription factor p63, a p53 homo-
log, has recently been shown to identify keratinocyte stem
cells [10].
Apoptosis plays a fundamental role in epidermal homeo-
stasis by counterbalancing cell proliferation, thus maintaining
the proper cell number [11]. In the skin, although apoptosis
can be induced by di¡erent stimuli [12], it can also be phys-
iologically activated [13], while apoptotic cells are consistently
observed in normal human epidermis [14].
It has been shown that cell survival requires interaction
with the ECM and that integrin signaling controls cell death
in many cell settings [15]. Apoptosis occurs in certain cell
types, such as epithelial and endothelial cells following detach-
ment from the ECM [16,17].
In the present study, we show that keratinocytes most rap-
idly adhering to type IV collagen, expressing highest levels of
L1 and K6L4 integrins, and identi¢ed by p63, are protected
from cell death. We also present correlative evidence that the
balance of pro- and anti-apoptotic members of the Bcl-2 fam-
ily in the three keratinocyte populations plays a critical role in
preventing ‘anoikis’ in keratinocyte stem cells.
2. Materials and methods
2.1. Cell cultures
Keratinocytes were obtained from neonatal foreskin, as described in
[14]. Recovered keratinocytes were washed in serum-free medium and
plated onto plastic dishes, coated for 2 h at 37‡C with 100 Wg/ml type
IV collagen (Sigma, St. Louis, MO, USA). Keratinocytes were divided
into three populations and cultured in serum-free medium (KGM,
Clonetics, San Diego, CA, USA). They were ¢rst allowed to adhere
to type IV collagen for 5 min (population 1), and the non-adherent
cells were then transferred to fresh collagen-coated dishes and allowed
to attach overnight (population 2). Finally, keratinocytes not yet at-
tached after one night were plated onto type IV collagen to obtain a
third population (population 3). The three populations were then used
for further experiments. HaCaT keratinocytes, HaCaT cells trans-
fected with bcl-2(pcDNA1/Neo plus Bcl-2), HaCaT cells transfected
with pcDNA1/Neo minus Bcl-2 and control transfectants (a kind gift
of Anne Haake, University of Rochester, NY, USA [18]) were cul-
tured in Dulbecco’s modi¢ed Eagle’s medium plus 10% fetal calf se-
rum and were used for certain adhesion experiments. For blocking
adhesion experiments, keratinocytes were pre-incubated for 1 h at
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37‡C with anti-L1 integrin neutralizing antibody (1:250, Immuno-
tech), anti-vimentin antibody (1:250, Dako, Copenhagen, Denmark)
or medium alone.
2.2. Immuno£uorescent staining and FACS
Cells from the three populations were resuspended in phosphate-
bu¡ered saline (PBS) at 4‡C, incubated on ice with anti-L1 integrin
monoclonal antibody (1:20, Immunotech, Marseille, France) for 30
min. Cells were then washed in PBS at 4‡C and incubated with the
anti-mouse secondary antibody FITC-conjugated for 30 min on ice.
After washing, cells were analyzed using a FACScan £ow cytometer
(Becton-Dickinson, San Jose¤, CA, USA) with Lysys II software (Bec-
ton-Dickinson).
2.3. Determination of CFE
Keratinocytes from the three di¡erent populations were harvested
by treatment with a trypsin/EDTA solution (0.05%/0.02%). Ten dishes
(6 mm q) were plated for each cell population at a density of 100 cells
per dish. Keratinocytes were cultured on mitomycin C-treated 3T3
cells (2.4U104/cm2 ; ATCC, Rockville, MD, USA) and cultivated in
Dulbecco’s modi¢ed Eagle’s medium and Ham’s F12 media for
2 weeks. Culture medium was changed after 6 days. Fourteen days
later, dishes were ¢xed and stained with crystal violet. Colonies that
contained more than 10 cells were counted and CFE was calculated.
The colony number was expressed as a percentage of the number of
basal cells plated in each dish.
2.4. Cell death analysis
Cells from populations 1 and 2 were ¢xed in situ in para-formal-
dehyde (4% in PBS), while cells from population 3 were collected and
cytospun onto slides precoated with 0.01% poly-L-lysine and air-dried
at 48 h. All cells were then stained with the terminal deoxynucleotidyl
transferase-mediated dUTP nick end labeling (TUNEL) method, as
described in [12]. Fluorescent specimens were analyzed by confocal
scanning laser microscopy (Leica TCS4D) in conjunction with a con-
ventional optical microscope (Leica DM IRBE). For £ow cytometric
analysis, cells were trypsinized after 48 h and resuspended (1U106
cells) in 400 Wl hypotonic £uorochrome solution: propidium iodide
(PI) 50 mg/ml in 0.1% sodium citrate containing 0.1% Triton X-100,
Sigma. After a 60 min incubation in this solution, cells were analyzed
using a FACScan.
2.5. Western blot analysis
Cells were washed with PBS and lysed on ice in RIPA bu¡er pH
7.5. Total protein (40 Wg) was analyzed under reducing conditions on
12% polyacrylamide gels and blotted onto nitrocellulose membranes.
The blots were blocked for 2 h in blocking bu¡er (PBS bu¡er, pH 7.4
with 0.2% Tween 20 and 5% non-fat milk) and incubated with anti-
human Bcl-2 (1:1000), Bax (1:1000), Bcl-x (1:1000), Mcl-1 (1:1000),
Bad (1:3000), p63 (vNp63K, 1:400, Santa Cruz Biotechnology, Santa
Cruz, CA, USA), K6L4 integrin (1:100, Santa Cruz Biotechnology)
and L-actin (1:1000, Sigma) overnight at 4‡C. Then membranes were
washed in PBS/Tween 20, incubated with peroxidase-conjugated goat
anti-mouse antibodies (1:800, Bio-Rad, Hercules, CA, USA) for p63,
K6L4 and L-actin for 45 min at room temperature, and with peroxi-
dase-conjugated goat anti-rabbit (1:3000) for Bcl-2, Bax, Bcl-x, Mcl-1
and Bad. Finally, membranes were washed and developed using the
ECL chemiluminescent detection system (Amersham).
3. Results
3.1. Characterization of keratinocytes enriched for stem cells
Because epidermal stem cells have previously been isolated
based on their L1 integrin expression [19], we selected three
populations according to their di¡erent adhesive capacities to
type IV collagen. Cells that rapidly (5 min) attached to type
IV collagen (population 1) expressed highest levels of L1 in-
tegrin, whereas L1 integrin protein was signi¢cantly lower in
population 2 and almost undetectable in population 3 (Fig.
1A). Moreover, K6L4 integrin was strongly expressed in pop-
ulation 1, to a lesser degree in population 2 and absent in
population 3 (Fig. 1B). We also demonstrated that population
Fig. 1. Isolation of keratinocytes enriched for stem cells. Cell sus-
pensions from the three keratinocyte populations were immuno-
stained using antibody speci¢c for L1 integrin, as described in Sec-
tion 2. Cells were analyzed by £ow cytometry. The results are
expressed as the meanUS.D. of three experiments. Student’s t-test
was used for comparison of the means (A). Cells from the three
populations were lysed at 48 h and protein analyzed by Western
blotting using anti-K6L4 (B) and anti-p63 (C) monoclonal antibod-
ies, as described in Section 2. Relative intensity of bands on autora-
diograms was quanti¢ed by scanning laser densitometry. CFE was
determined on the three keratinocyte populations, as described in
Section 2. Results are expressed as the meanUS.D. of three di¡erent
experiments. Student’s t-test was used for comparison of the means
(D, E).
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1 expressed highest levels of p63, whereas this protein was
barely detectable in population 2 and absent in population 3
(Fig. 1C), in agreement with previous reports [10]. Finally,
cells from population 1 had the highest CFE, while CFE
was signi¢cantly decreased in population 2 and virtually un-
detectable in population 3 (Fig. 1D). Taken together, these
results indicate that we isolated a population of keratinocytes
enriched for stem cells, a population of ‘young’ TA cells and a
population of terminally di¡erentiated cells.
3.2. Apoptosis (‘anoikis’) and adhesiveness
Because lack of matrix attachment can cause apoptosis in
other cell systems [20], we reasoned that keratinocytes from
population 1, that most rapidly adhered to type IV collagen,
could be protected from programmed cell death by survival
signals generated via integrin activation [21]. Indeed, apopto-
tic keratinocytes were almost undetectable in population 1
and signi¢cantly more numerous in populations 2 and 3
(Fig. 2A). Fig. 2B illustrates large colonies formed by cells
from population 1 at 48 h, while keratinocytes from popula-
tion 2 formed only small colonies. As expected, population 3
showed only detached cells (Fig. 2B). Moreover, the percent-
age of TUNEL-positive cells was signi¢cantly higher in pop-
ulations 2 and 3 than in population 1 (Fig. 2C,D). The above
¢ndings show that keratinocytes enriched for stem cells are
e¡ectively protected from apoptosis.
3.3. Protection from apoptosis (‘anoikis’) is mediated by
integrins
Because integrin signaling is a general requirement for cell
survival [22], we evaluated the role of L1 integrin in mediating
protection from apoptosis in keratinocytes rapidly adhering to
Fig. 2. Keratinocytes enriched for stem cells are protected from apo-
ptosis. Cells were stained with PI and analyzed by £ow cytometry.
Results are expressed as the meanUS.D. of PI-positive cells in the
sub-G1 peak, indicating apoptosis, from three di¡erent experiments.
Student’s t-test was used for comparison of the means (A). Kerati-
nocyte colonies from the three populations were observed and pho-
tographed at 48 h under phase contrast (B). Cells from the three
populations were stained by the TUNEL technique. Approximately
100 cells were evaluated, in randomly selected high power ¢elds and
the percentage of TUNEL-positive cells was counted. Each experi-
ment was repeated three times. Results are expressed as the mean
percentageUS.D. from three experiments. Student’s t-test was used
for comparison of the means (C, D).
Fig. 3. Integrins mediate protection of keratinocyte stem cells from
apoptosis. Keratinocytes from populations 1 (black bar) and 2 (gray
bar) were pre-incubated for 1 h at 37‡C with anti-L1 integrin neu-
tralizing antibody, anti-vimentin antibody or medium alone, as de-
scribed in Section 2. Then keratinocytes were allowed to adhere to
type IV collagen and stained by the TUNEL technique at 24 h. Cell
counting and statistics were performed as before (A). Keratinocytes
from population 1 were treated as above and Bcl-2 protein level an-
alyzed by Western blot, as described in Section 2. L-Actin levels
were evaluated to assess equal loading of the protein. The relative
intensity of bands on autoradiograms was quanti¢ed by scanning la-
ser densitometry. Values are expressed as fold variations compared
to control cells (B).
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type IV collagen. To this purpose, we treated keratinocytes
from populations 1 and 2 with anti-L1 integrin neutralizing
antibody. This antibody induced a signi¢cantly increased per-
centage of apoptotic cells both in population 1 and in pop-
ulation 2, as compared to untreated keratinocytes. By con-
trast, the addition of anti-vimentin antibody failed to
augment the number of apoptotic cells (Fig. 3A). As integrin
mediates cell survival by increasing the expression of Bcl-2
protein in other cell systems [23], we evaluated the levels of
this anti-apoptotic protein after treating keratinocytes en-
riched for stem cells with anti-L1 integrin neutralizing anti-
body. Addition of anti-L1 integrin resulted in a clear decrease
in Bcl-2 levels (Fig. 3B).
3.4. The Bcl-2 family regulates apoptosis
Various members of the Bcl-2 family are expressed in basal
keratinocytes [23,24] and have been shown to regulate apo-
ptosis in these cells [25,26,27]. Therefore, we measured the
levels of pro- and anti-apoptotic proteins of the Bcl-2 family
in the three populations. Levels of Bcl-2, Bcl-X and Mcl-1
proteins were markedly higher in population 1 than in pop-
ulation 2, while they were nearly absent in population 3. By
contrast, Bax and Bad were inversely correlated to the anti-
apoptotic proteins in the same populations, in that their levels
were markedly lower in population 1 than in population 2,
while they were highest in population 3 (Fig. 4A,B).
To further de¢ne the role of Bcl-2 in protection from ‘anoi-
kis’, the spontaneously immortalized HaCaT cell line overex-
pressing Bcl-2 (HaCaT plus), HaCaT cells not expressing
Bcl-2 (HaCaT minus), parental HaCaT cells and control
transfectants (mock) (Fig. 5B) were pretreated with anti-L1
integrin antibody and plated onto type IV collagen. While
few apoptotic cells were detected in untreated HaCaT cells
or in HaCaT cells pretreated with anti-vimentin antibody,
following treatment with anti-L1 integrin antibody, the num-
ber of apoptotic HaCaT keratinocytes was signi¢cantly re-
duced in cells HaCaT plus Bcl-2 as compared to both parental
HaCaT cells and to control transfectants. On the other hand,
upon treatment with anti-L1 integrin antibody, the number of
apoptotic cells in HaCaT minus Bcl-2 was signi¢cantly higher
than in controls (Fig. 5A).
4. Discussion
Keratinocyte stem cells have been de¢ned by various char-
acteristics, such as location within the tissue [28], mitotic be-
Fig. 4. Bcl-2 family expression. Cells from the three populations
were lysed at 48 h and protein analyzed by Western blotting using
anti-Bcl-2, Bcl-x, Mcl-1, Bax, Bad and L-actin polyclonal antibodies,
as described in Section 2 (A). The relative intensity of bands on
autoradiograms was quanti¢ed by scanning laser densitometry (B).
Fig. 5. Bcl-2 protects keratinocyte stem cells from apoptosis. HaCaT
cells not expressing Bcl-2, HaCaT cells overexpressing Bcl-2, paren-
tal HaCaT cells and control transfectants were pre-incubated with
anti-L1 integrin antibody or with anti-vimentin, as a control.
HaCaT cells were then allowed to adhere to type IV collagen and
stained with the TUNEL technique at 24 h. Cell counting and sta-
tistics were performed as before. HaCaT minus Bcl-2 vs. HaCaT
cells and control transfectants (mock): P6 0.01; HaCaT plus Bcl-2
vs. HaCaT cells and control transfectants (mock): P6 0.01 (A).
HaCaT cells not expressing Bcl-2, HaCaT cells overexpressing Bcl-2,
parental HaCaT cells and control transfectants were lysed at sub-
con£uency and protein analyzed by Western blotting using anti-
Bcl-2 polyclonal antibody (B).
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havior [29,30], morphology [31] and expression of protein
markers [32,33]. However, little is known of their resistance
to apoptosis. We report here that a subpopulation of kerati-
nocytes enriched for stem cells is protected from cell death,
while keratinocytes with the characteristics of ‘young TA’ and
TA cells are signi¢cantly more susceptible to apoptosis. Pre-
vious studies have indicated that the apoptotic process may
indeed regulate the fate of stem cells in other epithelial sys-
tems such as the intestinal crypts [34,35]. In the murine epi-
dermal system in vitro, upon TPA treatment, while maturing
basal cells undergo apoptosis, slowly cycling, label-retaining
cells that correlate to stem keratinocytes remain attached and
seem to be resistant to TPA [36].
Keratinocytes enriched for stem cells in our system express
highest levels of the transcription factor p63, which has been
reported as a keratinocyte stem cell marker [10]. Moreover,
the vN isoform of p63 [37], used in our study, decreases in
basal keratinocytes after UV-B irradiation and such a down-
regulation is required for UV-B-induced apoptosis in epider-
mis [38]. These ¢ndings point to an anti-apoptotic role for p63
in keratinocytes. Most of all, this well correlates with the
observation, reported in this study, of a subpopulation of
keratinocytes enriched for stem cells, strongly expressing
p63, that are protected from apoptosis.
We also provide evidence that keratinocyte stem cell surviv-
al is supported by cell^matrix interaction. Indeed, the method
of sorting stem cell population used in our study is based on
the adhesiveness mediated by integrins [19] : keratinocytes
most rapidly adhering to type IV collagen are more resistant
to apoptosis. Secondly, inhibition of L1 integrin function in-
creases apoptosis in keratinocyte stem cell populations. Con-
trol of cell survival by integrins occurs in other cell systems.
Inhibition of integrin-mediated cell^ECM adhesion induces
apoptosis in bronchial epithelial cells [39] and integrin KvL3
rescues melanoma cells from apoptosis [40]. While blocking
keratinocyte adhesion to ECM was shown to increase the
sensitivity of these cells to UV-induced apoptosis [41], our
study ¢rst demonstrates that spontaneous apoptosis is pre-
vented in keratinocyte stem cells, by virtue of their rapid
attachment to type IV collagen via L1 integrin. Although an
anti-apoptotic role of other integrins in keratinocyte stem cells
cannot be ruled out, the addition of anti-L1 integrin antibody
clearly increases the rate of cell death in our cell populations.
This indicates that L1 integrin is a key adhesion molecule for
protecting keratinocyte stem cells from apoptosis.
It is interesting to note that L1 integrin protects cells from
apoptosis through the induction of Bcl-2 expression [20]. Bcl-2
expression is often topographically restricted to long-lived or
proliferating cell compartments [42]. Furthermore, a small
subset of slowly cycling basal epithelial cells expressing high
levels of bcl-2 has recently been characterized [43]. Consistent
with this observation, we show that a subpopulation of basal
keratinocytes enriched for stem cells expresses high levels of
anti-apoptotic members of the Bcl-2 family, while levels of
pro-apoptotic proteins are nearly absent in these cells. Fur-
thermore, Bcl-2 overexpression prevents apoptosis caused by
the inhibition of cell^ECM interaction, while blocking Bcl-2
expression in anti-L1 integrin-treated cells induces a signi¢-
cantly higher rate of apoptosis as compared to controls. Fi-
nally, anti-L1 integrin reduced the levels of Bcl-2 protein in
stem keratinocytes. This indicates that keratinocyte stem
cells are protected from ‘anoikis’ through a Bcl-2 dependent
pathway, as previously reported for epithelial cell lines
[16].
Rescue from apoptosis in epidermal stem cells could con-
tribute to skin carcinogenesis [44], while integrin signaling
functions may o¡er targets for tumor therapy [45].
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